16 results on '"Vaugier, Loig"'
Search Results
2. Salvage radiotherapy after initial cryotherapy for localized prostate cancer: A systematic review of the literature
- Author
-
Rogé, Maximilien, Perennec, Tanguy, Guimas, Valentine, Hetet, Jean-François, Rio, Emmanuel, Vaugier, Loïg, and Supiot, Stéphane
- Published
- 2023
- Full Text
- View/download PDF
3. Long-term Outcomes and Patterns of Relapse Following High-dose Elective Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Nodes in Prostate Cancer: OLIGOPELVIS (GETUG-P07).
- Author
-
Vaugier, Loig, Morvan, Cyrille, Pasquier, David, Buthaud, Xavier, Magné, Nicolas, Beckendorf, Veronique, Sargos, Paul, Crehange, Gilles, Pommier, Pascal, Loos, Genevieve, Hasbini, Ali, Latorzeff, Igor, Silva, Marlon, Paul, Julie, Blanc-Lapierre, Audrey, and Supiot, Stéphane
- Subjects
- *
LYMPH node cancer , *ANDROGEN deprivation therapy , *PROSTATE-specific antigen , *DISEASE progression , *PROSTATE cancer - Abstract
Pelvic radiotherapy offered prolonged tumor control for oligorecurrent prostate cancer in pelvic lymph nodes, and grade 2+ toxicity remained below 15%. Approximately one-third of patients were still in complete remission after 5 yr. Para-aortic lymph nodes were the main sites of relapse. Androgen deprivation therapy (ADT) is a mainstay in metastatic prostate cancer, while additional salvage radiotherapy may offer prolonged remission for patients with regional node relapses. We performed an open-label, phase II trial to assess the long-term outcomes and patterns of relapse of 6-months ADT and elective pelvic radiotherapy in men with oligorecurrent (<6) pelvic nodes in prostate cancer (Oligopelvis GETUG-P07). We analyzed the 5-yr outcomes. Progression was defined as two consecutive prostate-specific antigen levels above the level at inclusion and/or clinical progression as per RECIST 1.1 and/or death from any cause. Sixty-seven patients were recruited. The median follow-up was 6.1 yr (95%CI: 5.9-6.3). Grade 2+ 3-yr, 4-yr and 5-yr genito-urinary and gastro-intestinal toxicities affected 15%, 9%, 4% and 2%, 3%, 4% of non-progressive patients, respectively. 5-yr progression-free, biochemical relapse–free and ADT-free survivals were 39%, 31% and 64%, respectively. In total, 45 patients had progression and 38 had the following clinical progression: local (18%), N1 (29%), M1a (50%), M1b (32%) and M1c (11%). Finally, combined elective pelvic radiotherapy and ADT appeared to prolong tumor control with limited toxicity. At 5 years, one third of patients had not relapsed biochemically. The major site of relapse was para-aortic lymph nodes. [ABSTRACT FROM AUTHOR]
- Published
- 2025
- Full Text
- View/download PDF
4. A Multicenter Study Assessing the Real-World Use and Effectiveness of First-Line Chemotherapy Plus Immunotherapy in Advanced Small-Cell Lung Cancer (SCLC) Patients
- Author
-
Porte, Marie, Vaudron, Adrien, Crequit, Perrine, Vaugier, Loig, Chatellier, Thierry, Fronteau, Clémentine, Raimbourg, Judith, Goronflot, Thomas, Bennouna, Jaafar, and Pons-Tostivint, Elvire
- Published
- 2024
- Full Text
- View/download PDF
5. OLIGOPELVIS GETUG P07, a Multicenter Phase II Trial of Combined High-dose Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Node Relapses in Prostate Cancer
- Author
-
Supiot, Stéphane, Vaugier, Loig, Pasquier, David, Buthaud, Xavier, Magné, Nicolas, Peiffert, Didier, Sargos, Paul, Crehange, Gilles, Pommier, Pascal, Loos, Genevieve, Hasbini, Ali, Latorzeff, Igor, Silva, Marlon, Denis, Fabrice, Lagrange, Jean-Léon, Morvan, Cyrille, Campion, Loic, and Blanc-Lapierre, Audrey
- Published
- 2021
- Full Text
- View/download PDF
6. 1936: A dosimetric parameter to improve local control on colorectal cancer lung metastasis treated by SABR
- Author
-
Morcet-Delattre, Robin, Castelli, Joël, Vaugier, Loïg, Bourbonne, Vincent, Scodan, Romuald Le, Lapierre, Ariane, Argo-Leignel, Delphine, and Duvergé, Loïg
- Published
- 2024
- Full Text
- View/download PDF
7. Rare-earth vs. heavy metal pigments and their colors from first principles
- Author
-
Tomczak, Jan M., Pourovskii, Leonid V., Vaugier, Loig, Georges, Antoine, and Biermann, Silke
- Published
- 2013
8. The Sentinel Lymph Node in Treatment Planning: A Narrative Review of Lymph-Flow-Guided Radiotherapy.
- Author
-
Ah-Thiane, Loic, Rousseau, Caroline, Aumont, Maud, Cailleteau, Axel, Doré, Mélanie, Mervoyer, Augustin, Vaugier, Loig, and Supiot, Stéphane
- Subjects
MEDICAL radiology ,MEDICAL protocols ,SENTINEL lymph nodes ,TUMORS ,RADIOTHERAPY ,MEDICAL drainage ,DECISION making in clinical medicine ,CANCER patient medical care ,ONCOLOGY ,ONCOLOGISTS - Abstract
Simple Summary: The sentinel lymph node is a surgical technique developed in oncological surgery to identify and analyze fewer lymph nodes than a conventional lymph node dissection in order to limit the morbidity and mortality of such an extensive procedure without compromising the patients' outcomes. This concept seems to also be useful in radiation oncology that treats lymph node areas. This may help radiation oncologists to treat their patients more precisely by targeting more accurately pathological sites and sparing healthy tissues. The aim of this review is to highlight the feasibility and level of proof regarding the use of this technique for treatment planning in radiation oncology. The sentinel lymph node technique is minimally invasive and used routinely by surgeons, reducing the need for morbid extensive lymph node dissections, which is a significant advantage for cancer staging and treatment decisions. The sentinel lymph node could also help radiation oncologists to identify tumor drainage for each of their patients, leading to a more personalized radiotherapy, instead of a probabilistic irradiation based on delineation atlases. The aim is both to avoid recurrence in unexpected areas and to limit the volume of irradiated healthy tissues. The aim of our study is to evaluate the impact of sentinel lymph node mapping for radiation oncologists. This concept, relying on sentinel lymph node mapping for treatment planning, is known as lymph-flow-guided radiotherapy. We present an up-to-date narrative literature review showing the potential applications of the sentinel lymph node technique for radiotherapy, as well as the limits that need to be addressed before its routine usage. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. Abscopal Response in Metastatic Melanoma: Real-World Data of a Retrospective, Multicenter Study.
- Author
-
Ollivier, Luc, Orione, Charles, Bore, Paul, Misery, Laurent, Legoupil, Delphine, Leclere, Jean-Christophe, Coste, Anne, Girault, Gilles, Sicard-Cras, Iona, Kacperek, Clemence, Lucia, Francois, Stefan, Dinu, Thillays, François, Rio, Emmanuel, Lesueur, Paul, Berthou, Christian, Heymann, Dominique, Champiat, Stéphane, Supiot, Stéphane, and Vaugier, Loig
- Subjects
MELANOMA prognosis ,RESEARCH ,ACADEMIC medical centers ,IMMUNE checkpoint inhibitors ,MELANOMA ,MULTIVARIATE analysis ,METASTASIS ,RETROSPECTIVE studies ,TREATMENT effectiveness ,CANCER patients ,COMPARATIVE studies ,INFECTION ,DESCRIPTIVE statistics ,RADIOTHERAPY ,PROGRESSION-free survival ,COMBINED modality therapy ,PALLIATIVE treatment ,IMMUNOTHERAPY ,EVALUATION - Abstract
Simple Summary: An abscopal response (AR) is a rare phenomenon defined as a distant response outside of the radiation field. It opens up the perspective of "in situ" vaccination of cancer. This phenomenon is rare and its mechanisms are unknown. In metastatic melanoma (MM), the approach regarding the efficacy of immunotherapy is to not use immunotherapy as a tool for enhancing radiation response but rather as one that needs to be integrated into immunotherapy to potentiate the specific effects of immunotherapy. The aim of our retrospective study was to investigate the incidence of the AR and its impact on therapeutic outcomes in a homogeneous population of patients with MM and a control group, to identify the factors associated with the AR. AR in metastatic melanoma seems highly prognostic of overall survival although it is a rare phenomenon. Factors associated with AR have been identified. Objective: To evaluate the incidence of the abscopal response (AR) in patients with metastatic melanoma requiring palliative radiotherapy (RT). Patients and methods: Patients treated for metastatic melanoma between January 1998 and February 2020 in four oncology departments were screened. Patients with progression under immune checkpoint inhibitors or without ongoing systemic treatment, and requiring palliative RT were considered. The AR was defined as an objective response according to RECIST and/or iRECIST for at least one non-irradiated metastasis at distance (≥10 cm) from the irradiated lesion. Primary endpoint was the rate of AR. Secondary endpoints were overall survival (OS), progression-free survival (PFS), local control (LC) of the irradiated lesion, and toxicity as assessed by CTCAE v5. Results: Over the period considered, 118 patients were included and analyzed. Fifteen patients (12.7%) had an AR. With a median follow-up of 7.7 months (range, 0.2–242.2), median OS and PFS after RT were significantly longer in patients with an AR compared to those without: 28 vs. 6.6 months (p < 0.01) and not reached vs. 3.2 months, respectively. No grade ≥2 toxicity was reported. Patients who developed an AR were more likely to be treated with immunotherapy (93.3% vs. 55.9%, p = 0.02). In multivariate analysis, they had a higher number of irradiated metastases treated concomitantly (HR = 16.9, p < 0.01) and a higher rate of mild infections during RT (HR = 403.5, p < 0.01). Conclusions: AR in metastatic melanoma seems to be highly prognostic of overall survival, although it is a rare phenomenon. It may be promoted by multiple concomitant treatments with RT and immunotherapy and by acute inflammatory events such as infection. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
10. Early toxicity of a phase II trial of combined salvage radiotherapy and hormone therapy in oligometastatic pelvic node relapses of prostate cancer (OLIGOPELVIS GETUG P07)
- Author
-
Vaugier, Loig, Palpacuer, Clément, Rio, Emmanuel, Goineau, Aurore, Pasquier, David, Buthaud, Xavier, De Laroche, Guy, Beckendorf, Véronique, Sargos, Paul, Créhange, Gilles, Pommier, Pascal, Loos, Geneviève, Hasbini, Ali, Latorzeff, Igor, Silva, Marlon, Denis, Fabrice, Lagrange, Jean-Léon, Campion, Loïc, Supiot, Stephane, Bernardo, Elizabeth, Département de Radio-Oncologie [ICO, Nantes], Institut de Cancérologie de l'Ouest [Angers/Nantes] (UNICANCER/ICO), UNICANCER-UNICANCER, Département de Biostatistiques [ICO, Nantes], Service de la Radio-Oncologie [Angers], Centre Régional de Lutte contre le Cancer Oscar Lambret [Lille] (UNICANCER/Lille), Université de Lille-UNICANCER, Centre de Recherche en Informatique, Signal et Automatique de Lille - UMR 9189 (CRIStAL), Centrale Lille-Université de Lille-Centre National de la Recherche Scientifique (CNRS), Département de Radio-Oncologie [Nantes] (Centre Catherine de Sienne), Centre Catherine-de-Sienne [Nantes] (CCS), Département de Radio-Oncologie [Saint-Priest en Jarez] ( Institut de Cancérologie de la Loire), Institut de Cancérologie de la Loire [Saint-Priest en Jarez], Département de Radio-Oncologie [Vandoeuvre-lès-Nancy] (Centre Alexis Vautrin), Institut de Cancérologie de Lorraine - Alexis Vautrin [Nancy] (UNICANCER/ICL), Département de Radio-Oncologie [IB, Bordeaux] (Institut Bergonié), Institut Bergonié [Bordeaux], Service de radiothérapie [Centre Georges-François Leclerc], Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), Département de Radio-Oncologie [CLB, Lyon] (Centre Léon Bérard), Centre Léon Bérard [Lyon], Département de Radio-Oncologie [Clermont-Ferrand] (Centre Jean Perrin), Centre Jean Perrin [Clermont-Ferrand] (UNICANCER/CJP), Département de Radio-Oncologie [Brest] (Clinique Pasteur), Clinique Pasteur [Brest], Département de Radio-Oncologie [Toulouse] (Oncorad Clinique Pasteur), Oncorad Clinique Pasteur [Toulouse], Département de Radio-Oncologie [Baclesse, Caen], Centre Régional de Lutte contre le Cancer François Baclesse [Caen] (UNICANCER/CRLC), Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN), Centre Jean Bernard [Institut Inter-régional de Cancérologie - Le Mans], Département de Radio-Oncologie [AP-HP Hôpital Henri Mondor], Hôpital Henri Mondor, Integrative Oncogenomics of Multiple Myeloma Pathogenesis and Progression (CRCINA-ÉQUIPE 11), Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes), Endothelium Radiobiology and Targeting (CRCINA-ÉQUIPE 14), This study was funded by Astellas., Université Lille Nord de France (COMUE)-UNICANCER, Centre Alexis Vautrin [Vandoeuvre-lès-Nancy], Département de Radio-Oncologie [Dijon] (CGFL Dijon), UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), and Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA)
- Subjects
pelvic reirradiation ,PSMA PET ,[SDV.CAN] Life Sciences [q-bio]/Cancer ,pelvis salvage irradiation ,Fluorocholine PET ,bowel toxicity ,urinary toxicity ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,IMRT ,prostate cancer ,IGRT - Abstract
International audience; PURPOSE:Limited pelvic nodal relapse of prostatic cancer is a paramount challenge for locoregional salvage treatments. Salvage whole pelvis radiotherapy as considered in the BLINDED trial, is an attractive option but with concerns about its toxicity. This article describes early toxicity with the technique.METHODS AND MATERIALS:BLINDED was a prospective multi-center phase II trial investigating high-dose salvage pelvic irradiation with an additional dose to the fluorocholine-based positron-emission-tomography (FCH-PET)-positive pelvic lymph nodes (PLN), combined with six-month androgen blockade. The prescribed dose was 54 Gy in 1.8 Gy fractions with up to 66 Gy in 2.2 Gy fractions to the pathological PLN. Early toxicity was defined until one year after radiotherapy. Patients quality of life was assessed using the EORTC questionnaires (QLQ-C30 and QLQ-PR25).RESULTS:Seventy-four patients were recruited in fifteen French radiation oncology departments between August 2014 and July 2016. Seven were excluded before treatment because of violation of the inclusion criteria. The intention-to-treat analysis therefore included sixty-seven patients. Half of them had received prior prostatic irradiation. Median age was 67.7 ± 6.5 years. Grade 2 acute urinary toxicity was observed in 9/67 patients (13.4%) and grade 2 one-year toxicity in 4/67 patients (6%). Three patients (4.4%) had grade 3 urinary toxicity. Grade 2 acute digestive toxicity was observed in 10/67 patients (14.9%) and grade 2 one-year toxicity in 4/67 patients (6%). Patients with prior prostate bed irradiation did not exhibit increased urinary or digestive toxicity. EORTC questionnaire scores at one year did not worsen significantly.CONCLUSIONS:The acute and one-year toxicity of the BLINDED protocol was satisfactory, even in patients with a past history of prostatic irradiation.
- Published
- 2018
- Full Text
- View/download PDF
11. Electronic Structure of Correlated Materials From First Principles: Hubbard interaction and Hund's exchange
- Author
-
Vaugier, Loig and Vaugier, Loig
- Subjects
pnictures ,strongly correlated materials ,Coulomb interactions ,matériaux fortement corrélés ,constrained random phase approximation (cRPA) ,[PHYS.COND.CM-SCE] Physics [physics]/Condensed Matter [cond-mat]/Strongly Correlated Electrons [cond-mat.str-el] ,electronic structure from first principles ,Hund's coupling J ,Hund J ,écrantage électronique ,Hubbard U ,oxides ,electronic screening ,théorie du champ moyen dynamique (DMFT) ,dynamical mean-field theory (DMFT) ,interaction Coulombienne ,iron-based pnictides ,structure électronique ab initio ,oxydes - Abstract
In this thesis, we present a new implementation of the constrained Random Phase Approximation (cRPA) in a density functional code within the linearized augmented plane wave (LAPW) framework. The aim is to calculate - from first principles - the effective Coulomb interaction matrix for correlated solids, opening the way to a truly ab initio description within many-body calculations. In particular, we calculate the Hubbard parameter, U, and Hund's exchange, J, as well as their energy dependence arising from dynamical screening effects. As in the Wilson renormalization group, we stress that the effective Coulomb interactions crucially relie on the choice of the correlated subspace for which an effective low-energy Hamiltonian is constructed, although results for physical observables have to be the same at the end. A specific scheme for cRPA, based on a projection approach onto the low-energy subspace, is also introduced in order to deal with electronic structures where the target correlated orbitals are strongly entangled with the itinerant ones. Applications are shown for i) iron-based pnictides, LaOFeAs and BaFe2As2, and chalcogenides, FeSe (Chapter 6), ii) 3d transition metals to benchmark the projection scheme (Chapter 6) and iii) 3d and 4d transition metal perovskites, SrMO3 (M = V, Cr, Mn, Nb, Mo, Tc) and layered perovskites, Sr2MO4 (M = Mo, Tc, Ru, Rh) (Chapter 7). The cRPA values for the interaction Hamiltonian are combined with the dynamical mean-field theory (LDA+cRPA+DMFT) for the description of the spin-orbitally ordered Mott insulator Sr2IrO4, and the rare-earth fluorosulfide pigment, CeSF (Chapter 8)., Cette thèse propose une nouvelle implémentation de "l'approximation de la phase aléatoire avec polarisation contrainte" (constrained random phase approximation, cRPA). Notre implémentation repose sur la théorie de la fonctionnelle de la densité, développée dans une base d'ondes planes augmentées (linearized augmented plane wave, LAPW). Cette méthode, appliquée à des matériaux fortement corrélés, permet de calculer de facon réaliste la matrice d'interaction coulombienne effective, qui pourra être traitée par la suite au moyen de l'approche à N-corps souhaitée. En particulier, les valeurs de l'interaction de Hubbard, U , et de l'échange de Hund, J, sont déterminées de manière ab initio, ainsi que leur dépendance en fréquence qui résulte des effets dynamiques de l'écrantage. Comme dans la théorie du groupe de renormalisation de Wilson, l'interaction coulombienne effective dépend du choix du sous-espace corrélé pour lequel est construit un Hamiltonien effectif de basse énergie, alors que les valeurs des observables physiques n'en dépendent pas. Afin de généraliser la cRPA aux matériaux dont la structure électronique exhibe des orbitales corrélées et itinérantes intriquées, une méthode basée sur la projection sur le sous-espace corrélé est également introduite. Différentes classes de matériaux sont envisagées comme applications : i) pnictides à base de fer, LaOFeAs et BaFe2As2, et chalcogénides, FeSe (Chapitre 6), ii) métaux de transition 3d afin de valider notre méthode de projection (Chapitre 6), iii) oxydes de métaux de transition pérovskites, SrMO3 (M = V, Cr, Mn, Nb, Mo, Tc), et pérovskites en couches, Sr2MO4 (M = Mo, Tc, Ru, Rh) (Chapitre 7). L'Hamiltonien d'interaction cRPA est également couplé à la théorie du champ moyen dynamique (LDA+cRPA+DMFT) afin de décrire l'isolant de Mott induit par le couplage spin-orbite, Sr2IrO4, et le pigment à base de terre rare, CeSF (Chapitre 8).
- Published
- 2011
12. Long-range Coulomb interactions in surface systems: a first principles description within self-consistently combined GW and dynamical mean field theory
- Author
-
Hansmann, Philipp, Ayral, Thomas, Vaugier, Loig, Werner, Philipp, Biermann, Silke, Centre de Physique Théorique [Palaiseau] (CPHT), Centre National de la Recherche Scientifique (CNRS)-École polytechnique (X), Institut de Physique Théorique - UMR CNRS 3681 (IPHT), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS), University of Fribourg, Albert-Ludwigs-Universität Freiburg, Japan Science and Technology Agency (JST), IDRIS/GENCI under project 129313, ANR-09-BLAN-0210,SURMOTT(2009), École polytechnique (X)-Centre National de la Recherche Scientifique (CNRS), and Université de Fribourg = University of Fribourg (UNIFR)
- Subjects
[PHYS]Physics [physics] ,Condensed Matter - Strongly Correlated Electrons ,Strongly Correlated Electrons (cond-mat.str-el) ,FOS: Physical sciences ,cond-mat.str-el ,PACS numbers: 71.15.m, 71.10.Fd, 71.30.+h, 73.20.At - Abstract
Systems of adatoms on semiconductor surfaces display competing ground states and exotic spectral properties typical of two-dimensional correlated electron materials which are dominated by a complex interplay of spin and charge degrees of freedom. We report a fully ab initio derivation of low energy Hamiltonians for the adatom systems Si(111):X, with X=Sn, Si, C, Pb, that we solve within self-consistent combined GW and dynamical mean field theory ("GW+DMFT"). Calculated photoemission spectra are in agreement with available experimental data. We rationalize experimentally observed tendencies from Mott physics towards charge-ordering along the series as resulting from substantial long-range interactions., 5 pages, 4 figures
- Published
- 2013
- Full Text
- View/download PDF
13. Hubbard U and Hund's Exchange J in Transition Metal Oxides: Screening vs. Localization Trends from Constrained Random Phase Approximation
- Author
-
Vaugier, Loig, Jiang, Hong, and Biermann, Silke
- Subjects
Condensed Matter - Strongly Correlated Electrons ,Condensed Matter - Materials Science ,Strongly Correlated Electrons (cond-mat.str-el) ,Materials Science (cond-mat.mtrl-sci) ,FOS: Physical sciences - Abstract
In this work, we address the question of calculating the local effective Coulomb interaction matrix in materials with strong electronic Coulomb interactions from first principles. To this purpose, we implement the constrained random phase approximation (cRPA) into a density functional code within the linearized augmented plane wave (LAPW) framework. We apply our approach to the 3d and 4d early transition metal oxides SrMO3 (M=V, Cr, Mn) and (M=Nb, Mo, Tc) in their paramagnetic phases. For these systems, we explicitly assess the differences between two physically motivated low-energy Hamiltonians: The first is the three-orbital model comprising the t2g states only, that is often used for early transition metal oxides. The second choice is a model where both, metal d- and oxygen p-states are retained in the construction of Wannier functions, but the Hubbard interactions are applied to the d-states only ("d-dp Hamiltonian"). Interestingly, since -- for a given compound -- both U and J depend on the choice of the model, so do their trends within a family of these compounds. In the 3d perovskite series SrMO3 the effective Coulomb interactions in the t2g Hamiltonian decrease along the series, due to the more efficient screening. The inverse -- generally expected -- trend, increasing interactions with increasing atomic number, is however recovered within the more localized "d-dp Hamiltonian". Similar conclusions are established in the layered 4d perovskites series Sr2MO4 (M=Mo, Tc, Ru, Rh). Compared to their isoelectronic and isostructural 3d analogues, the 4d 113 perovskite oxides SrMO3 (M=Nb, Mo, Tc) exhibit weaker screening effects. Interestingly, this leads to an effectively larger U on 4d shells than on 3d when a t2g model is constructed., 21 pages, 7 figures
- Published
- 2012
14. Reduced effective spin-orbital degeneracy and spin-orbital ordering in paramagnetic transition metal oxides: Sr2IrO4 vs. Sr2RhO4
- Author
-
Martins, Cyril, Aichhorn, Markus, Vaugier, Loig, and Biermann, Silke
- Subjects
Condensed Matter::Materials Science ,Condensed Matter - Strongly Correlated Electrons ,Strongly Correlated Electrons (cond-mat.str-el) ,FOS: Physical sciences ,Condensed Matter::Strongly Correlated Electrons - Abstract
We discuss the notions of spin-orbital polarization and ordering in paramagnetic materials, and address their consequences in transition metal oxides. Extending the combined density functional and dynamical mean field theory scheme to the case of materials with large spin-orbit interactions, we investigate the electronic excitations of the paramagnetic phases of Sr2IrO4 and Sr2RhO4. We show that the interplay of spin-orbit interactions, structural distortions and Coulomb interactions suppresses spin-orbital fluctuations. As a result, the room temperature phase of Sr2IrO4 is a paramagnetic spin-orbitally ordered Mott insulator. In Sr2RhO4, the effective spin-orbital degeneracy is reduced, but the material remains metallic, due to both, smaller spin-orbit and smaller Coulomb interactions. We find excellent agreement of our ab-initio calculations for Sr2RhO4 with angle-resolved photoemission, and make predictions for spectra of the paramagnetic phase of Sr2IrO4., 4+ pages, 4 figures
- Published
- 2011
15. Stereotactic Re-Irradiation for Local Recurrence after Radical Prostatectomy and Radiation Therapy: A Retrospective Multicenter Study.
- Author
-
Perennec, Tanguy, Vaugier, Loig, Toledano, Alain, Scher, Nathaniel, Thomin, Astrid, Pointreau, Yoann, Janoray, Guillaume, De Crevoisier, Renaud, and Supiot, Stéphane
- Subjects
- *
RESEARCH , *BIOCHEMISTRY , *CHRONIC pain , *PATIENT aftercare , *ANTIANDROGENS , *RADICAL prostatectomy , *CYSTITIS , *CANCER relapse , *RETROSPECTIVE studies , *MEDICAL cooperation , *TREATMENT effectiveness , *PHENOMENOLOGY , *CANCER patients , *DESCRIPTIVE statistics , *SURVIVAL analysis (Biometry) , *RADIOSURGERY , *SALVAGE therapy , *PROSTATE tumors , *DISEASE risk factors - Abstract
Simple Summary: Stereotactic body radiation therapy remains an understudied treatment option for local recurrence in the prostate bed after prostatectomy followed by radiation therapy. Ablative treatment of local recurrence could avoid or delay androgen deprivation therapy or next-generation antiandrogens. This study suggests that this treatment modality could be a valuable option if confirmed by a prospective study, but long-term toxicity may be a significant limitation. Prostate cancer recurrence in patients previously treated with radical prostatectomy and radiation therapy is challenging. Re-irradiation could be an option, but data regarding efficacy and safety are lacking. We retrospectively evaluated salvage re-irradiation for local recurrence after prostatectomy and external beam radiation therapy. We collected data from 48 patients who underwent salvage reirradiation with stereotactic radiation therapy for local prostate cancer recurrence in the prostatic bed at four French centers. Fifteen patients (31%) were on androgen deprivation therapy during stereotactic radiotherapy. Biochemical response and relapse-free survival were analyzed, and post-treatment toxicities were assessed according to the Common Terminology of Adverse Events criteria. Five patients had grade 3 late bladder toxicity (cystitis), three had grade 3 late incontinence, and one had grade 3 late chronic pain. At three months, 83% of patients had a positive biochemical response. The median follow-up was 22 months. At the end of the follow-up, 21 patients (43%) had a biochemical relapse. The median time to biologic relapse was 27 months. The biochemical relapse rates at 1 and 2 years were 80% and 52%, respectively. In conclusion, salvage re-irradiation for recurrent prostate cancer in the prostate bed may generate significant toxicity rates, and a prospective study with appropriate patient selection is needed to evaluate its effectiveness. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
16. Towards a First-Principles Determination of Effective Coulomb Interactions in Correlated Electron Materials: Role of Intershell Interactions.
- Author
-
Seth, Priyanka, Hansmann, Philipp, van Roekeghem, Ambroise, Vaugier, Loig, and Biermann, Silke
- Subjects
- *
COULOMB functions , *NUCLEAR cluster model , *ELECTRONIC structure - Abstract
The determination of the effective Coulomb interactions to be used in low-energy Hamiltonians for materials with strong electronic correlations remains one of the bottlenecks for parameter-free electronic structure calculations. We propose and benchmark a scheme for determining the effective local Coulomb interactions for charge-transfer oxides and related compounds. Intershell interactions between electrons in the correlated shell and ligand orbitals are taken into account in an effective manner, leading to a reduction of the effective local interactions on the correlated shell. Our scheme resolves inconsistencies in the determination of effective interactions as obtained by standard methods for a wide range of materials, and allows for a conceptual understanding of the relation of cluster model and dynamical mean field-based electronic structure calculations. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.